{
  "items": "28",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "SBC Medical Group Holdings (SBC) Stock: Expands Japan Footprint After Waqoo Tender Offer Completion",
      "url": "https://coincentral.com/sbc-medical-group-holdings-sbc-stock-expands-japan-footprint-after-waqoo-tender-offer-completion/",
      "time_published": "20251215T130918",
      "authors": [
        "Yasmin Werner"
      ],
      "summary": "SBC Medical Group Holdings (SBC) has completed its tender offer for Waqoo, Inc. shares at JPY 1,900 each, acquiring over 575,000 shares for JPY 1.09 billion. This transaction significantly expands SBC's presence in Japan's healthcare market, particularly in regenerative medicine and R&D, by granting it effective control over Waqoo. This strategic move aligns with SBC's broader goal to grow its healthcare technology footprint in Asia and leverage Japan's demand for advanced treatments.",
      "banner_image": "https://coincentral.com/wp-content/uploads/2025/11/finance-1024x683-1.webp",
      "source": "CoinCentral",
      "category_within_source": "General",
      "source_domain": "CoinCentral",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.900104"
        }
      ],
      "overall_sentiment_score": 0.418966,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.428054",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Inc Announces Final Results of Tender Offer for Waqoo, Inc.",
      "url": "https://www.tradingview.com/news/tradingview:a8b6596598706:0-sbc-medical-group-holdings-inc-announces-final-results-of-tender-offer-for-waqoo-inc/",
      "time_published": "20251215T110918",
      "authors": [
        "NULL"
      ],
      "summary": "SBC Medical Group Holdings Inc announced the final results of its tender offer for Waqoo, Inc., with plans to acquire 575,052 shares at \u00a51,900 each. This acquisition is expected to give SBC Medical over 50% ownership in Waqoo, strengthening its R&D capabilities in regenerative medicine and its presence in the Japanese market. Settlement is scheduled to begin on December 19, 2025.",
      "banner_image": "NULL",
      "source": "TradingView \u2014 Track All Markets",
      "category_within_source": "General",
      "source_domain": "TradingView \u2014 Track All Markets",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.922612"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.721866"
        }
      ],
      "overall_sentiment_score": 0.435721,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.430558",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares",
      "url": "https://www.businesswire.com/news/home/20251213679885/en/SBC-Medical-Group-Holdings-Announcement-of-Final-Results-of-Tender-Offer-for-Waqoo-Inc.-Shares",
      "time_published": "20251213T040932",
      "authors": [
        "NULL"
      ],
      "summary": "SBC Medical Group Holdings Incorporated announced the successful completion of its tender offer for Waqoo, Inc. shares, acquiring 575,052 common shares at JPY 1,900 each. This acquisition, along with an off-market transfer from Waqoo's largest shareholder, will result in SBC Medical exceeding 50% ownership and becoming Waqoo, Inc.'s parent company. The strategic move enhances SBC Medical's healthcare technology capabilities and strengthens its presence in the Japanese market.",
      "banner_image": "https://mms.businesswire.com/media/20251213679885/en/2666666/4/SBC_logo_H_Gray_%286%29.jpg",
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.802723"
        },
        {
          "topic": "finance",
          "relevance_score": "0.702239"
        }
      ],
      "overall_sentiment_score": 0.445515,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.424411",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results",
      "url": "https://www.tradingview.com/news/reuters.com,2025-12-01:newsml_NFC7Px5HN:0-emerging-growth-research-reiterates-buy-extended-rating-on-sbc-medical-group-holdings-inc-with-9-00-price-target-following-q3-25-results/",
      "time_published": "20251203T170857",
      "authors": [
        "NULL"
      ],
      "summary": "Emerging Growth Research has reiterated a Buy-Extended rating for SBC Medical Group Holdings, Inc. following its Q3:25 results and maintained a $9.00 price target, signaling significant upside. The report highlights SBC's sequential revenue stabilization, operating profit growth, strong cash position, and strategic plans for renewed growth and expansion starting in 2026. The firm's analysis underscores SBC's operational discipline and attractive valuation within the fragmented global cosmetic treatment industry.",
      "banner_image": "NULL",
      "source": "TradingView \u2014 Track All Markets",
      "category_within_source": "General",
      "source_domain": "TradingView \u2014 Track All Markets",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.918551"
        },
        {
          "topic": "finance",
          "relevance_score": "0.716971"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.630721"
        }
      ],
      "overall_sentiment_score": 0.464483,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.471361",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results",
      "url": "https://finance.yahoo.com/news/emerging-growth-research-reiterates-buy-193500684.html",
      "time_published": "20251201T180842",
      "authors": [
        "NULL"
      ],
      "summary": "Emerging Growth Research has reiterated a Buy-Extended rating for SBC Medical Group Holdings, Inc. (NASDAQ: SBC) with a $9.00 price target, following the release of its Q3:25 quarterly update. The report highlights SBC's sequential revenue and operating profit stabilization, strong cash position, and anticipates renewed growth beginning in early 2026. This assessment suggests a significant upside from the Company's recent closing price of $3.57.",
      "banner_image": "https://s.yimg.com/ny/api/res/1.2/GxO2uXDiKQqbTMtjjcyejQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMjtoPTQ4O2NmPXdlYnA-/https://s.yimg.com/os/creatr-uploaded-images/2021-03/6700d450-7c69-11eb-9fef-632525639065",
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.903119"
        },
        {
          "topic": "finance",
          "relevance_score": "0.846643"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.739548"
        }
      ],
      "overall_sentiment_score": 0.4467,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.422171",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group stock rises on Thai market expansion plans",
      "url": "https://www.investing.com/news/stock-market-news/sbc-medical-group-stock-rises-on-thai-market-expansion-plans-93CH-4380148",
      "time_published": "20251201T050127",
      "authors": [
        "Investing.com"
      ],
      "summary": "SBC Medical Group Holdings Inc. (NASDAQ:SBC) stock gained 2.6% after announcing plans to expand into Thailand's aesthetic medicine market through a partnership with BLEZ ASIA. The company will provide management support for a new dermatological clinic in Bangkok, targeting Japanese expatriates and the broader Thai market projected to reach $1.2 billion by 2033. This move follows SBC's recent entry into Singapore.",
      "banner_image": "https://i-invdn-com.investing.com/news/LYNXMPEA7D094_L.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.913745"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.703230"
        }
      ],
      "overall_sentiment_score": 0.317635,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.485189",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "AVGO",
          "relevance_score": "0.593817",
          "ticker_sentiment_score": "0.144103",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group Continues International Expansion, Partners With BLEZ ASIA For Launch In Thailand This Year",
      "url": "https://www.newmediawire.com/news/sbc-medical-group-continues-international-expansion-partners-with-blez-asia-for-launch-in-thailand-this-year-7084409",
      "time_published": "20251201T050127",
      "authors": [
        "Meg Flippin"
      ],
      "summary": "SBC Medical Group is expanding its international presence by partnering with BLEZ ASIA for a launch in Thailand aimed at the local and Japanese expatriate communities. The venture will establish a new clinic focused on dermatological treatments, leveraging SBC's expertise and BLEZ ASIA's local trust. This move follows SBC's Singapore expansion and targets Thailand's growing aesthetic medicine market, projected to reach $1.2 billion by 2033.",
      "banner_image": "https://www.newmediawire/_gallery/get_file/?file_id=69272b46ed6ae51454c408ec&file_ext=.3b4cf9e2ab507b58_6927130eda846f6040d59df5_1&page_id=69272b3eed6ae51454c408e4",
      "source": "NewMediaWire",
      "category_within_source": "General",
      "source_domain": "NewMediaWire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.941688"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.800601"
        }
      ],
      "overall_sentiment_score": 0.441594,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.437275",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group (NASDAQ: SBC) to support BLEZ Bangkok clinic opening by year-end",
      "url": "https://www.stocktitan.net/news/SBC/sbc-medical-group-enters-the-thai-market-through-partnership-with-agpdhs86um9r.html",
      "time_published": "20251127T150925",
      "authors": [],
      "summary": "SBC Medical Group Holdings has partnered with BLEZ ASIA Co., Ltd. to enter the Thai aesthetic medicine market, advising on a new dermatological clinic expected to open by year-end in Bangkok. This collaboration leverages SBC's expertise in Japanese-quality aesthetic medicine and BLEZ's strong local presence to initially target Japanese expatriates before expanding to the broader Thai market. The partnership is a key step in SBC's broader Asia expansion strategy, following its recent entry into Singapore.",
      "banner_image": "https://mms.businesswire.com/media/20251007584582/en/2644254/4/54335794_SBC_MEDICAL_GROUP_Image.jpg",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.933988"
        },
        {
          "topic": "finance",
          "relevance_score": "0.725607"
        }
      ],
      "overall_sentiment_score": 0.416223,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.440138",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Reports Improved Third Quarter Net Profit And Sequentially Higher Average Revenue Per Patient Visit, Company Sets Sights On Continued Expansion",
      "url": "https://www.newmediawire.com/news/sbc-medical-group-reports-improved-third-quarter-net-profit-and-sequentially-higher-average-revenue-per-patient-visit-company-sets-sights-on-continued-expansion-7084355",
      "time_published": "20251124T100400",
      "authors": [
        "Meg Flippin"
      ],
      "summary": "SBC Medical Group Holdings Inc. reported a significant improvement in net profit for the third quarter, reaching $13 million compared to $3 million a year ago, despite an 18% decrease in total revenue. This was attributed to a more typical cost structure and strategic shifts including pricing optimization, expansion into franchise locations, and targeting a higher-priced customer base. The company is also expanding internationally into Thailand and acquiring a majority stake in Waqoo to integrate technological assets, aiming for strong growth in 2026.",
      "banner_image": "https://www.newmediawire.com/_gallery/get_file/?file_id=692474b3ed6ae568421f097a&file_ext=.c906669d579d1fe8_6924679dda846f6040d59dd1_1&page_id=692474abed6ae568421f0972",
      "source": "NewMediaWire",
      "category_within_source": "General",
      "source_domain": "NewMediaWire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.921701"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.814838"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.702020"
        }
      ],
      "overall_sentiment_score": 0.489596,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.490155",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Reports Improved Third Quarter Net Profit And Sequentially Higher Average Revenue Per Patient Visit, Company Sets Sights On Continued Expansion",
      "url": "https://www.theglobeandmail.com/investing/markets/stocks/SBC/pressreleases/36286965/sbc-medical-group-reports-improved-third-quarter-net-profit-and-sequentially-higher-average-revenue-per-patient-visit-company-sets-sights-on-continued-expansion/",
      "time_published": "20251124T050127",
      "authors": [
        "Meg Flippin"
      ],
      "summary": "SBC Medical Group Holdings Inc. (NASDAQ: SBC) announced a significant improvement in net profit for the third quarter, driven by a return to a more typical cost structure and the execution of a strategic shift. The company's strategy includes expanding franchise locations, optimizing pricing, targeting higher-priced customers, and discontinuing its staffing business, which has led to sequentially higher average revenue per patient visit. SBC Medical is also pursuing international expansion, particularly in Thailand, and acquiring a stake in Waqoo to integrate technological assets and create synergies.",
      "banner_image": "NULL",
      "source": "The Globe and Mail",
      "category_within_source": "General",
      "source_domain": "The Globe and Mail",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.932689"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.811598"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.749863"
        }
      ],
      "overall_sentiment_score": 0.470035,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.472648",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC - SBC Medical Group Holdings Incorporated Latest Stock News & Market Updates",
      "url": "https://www.stocktitan.net/news/SBC/page-3.html",
      "time_published": "20251124T050127",
      "authors": [
        "NULL"
      ],
      "summary": "This page provides the latest news and market updates for SBC Medical Group Holdings Incorporated (Ticker: SBC), a company specializing in management services for cosmetic treatment clinics in Japan. It features official corporate communications, market developments, and strategic initiatives. Recent updates include SBC Medical's participation in the Emerging Growth Conference, expansion of its multi-brand strategy, and Q4 and full-year 2024 financial results.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.924080"
        }
      ],
      "overall_sentiment_score": 0.00832,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.004611",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.",
      "url": "https://en.antaranews.com/news/392173/sbc-medical-group-announces-commencement-of-tender-offer-for-shares-of-waqoo-inc",
      "time_published": "20251117T123500",
      "authors": [
        "ANTARA/Business Wire"
      ],
      "summary": "SBC Medical Group Holdings Incorporated announced a tender offer for shares of Waqoo, Inc. by its subsidiary, SBC Medical Group Co., Ltd. The move aims to integrate Waqoo\u2019s R&D capabilities to enhance SBC Group\u2019s offerings in clinical areas like AGA and orthopedics, and support regenerative medicine. The tender offer price is JPY 1,900 per share, with the offer period running from November 14 to December 12, 2025.",
      "banner_image": "https://cdn.antaranews.com/cache/1200x800/2020/03/23/Logo-BusinessWire-800x600.jpg",
      "source": "ANTARA News",
      "category_within_source": "General",
      "source_domain": "ANTARA News",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.836392"
        },
        {
          "topic": "finance",
          "relevance_score": "0.632636"
        }
      ],
      "overall_sentiment_score": 0.450742,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.466940",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Q3 2025 Financial Results",
      "url": "https://www.tradingview.com/news/tradingview:97a0d061a248a:0-sbc-medical-group-holdings-q3-2025-financial-results/",
      "time_published": "20251117T050127",
      "authors": [
        "NULL"
      ],
      "summary": "SBC Medical Group Holdings reported its financial results for Q3 2025, showing a significant 353% surge in net income to $13 million, with EPS of $0.12, despite an 18% decrease in total revenues to $43 million. The company attributes improved profitability to cost structure normalization and the absence of prior year one-time expenses, while focusing on dermatology multi-brand initiatives and overseas expansion.",
      "banner_image": "NULL",
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.928716"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.733905"
        }
      ],
      "overall_sentiment_score": 0.405436,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.381383",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results",
      "url": "https://www.businesswire.com/news/home/20251114574234/en/SBC-Medical-Group-Holdings-Announces-Third-Quarter-2025-Financial-Results",
      "time_published": "20251117T050127",
      "authors": [],
      "summary": "SBC Medical Group Holdings announced its third-quarter 2025 financial results, with total revenues decreasing by 18% year-over-year to $43 million, primarily due to business restructuring. Despite the revenue decline, net income attributable to SBC Medical Group increased significantly by 353% to $13 million, driven by lower operating expenses and the absence of prior-year IPO-related costs. The company's CEO highlighted improved profitability and a focus on sustainable growth, multi-brand initiatives in dermatology, and global expansion.",
      "banner_image": "https://mms.businesswire.com/media/20251114574234/en/2644169/4/SBC_logo_H_Gray_%286%29.jpg",
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.833203"
        }
      ],
      "overall_sentiment_score": 0.341799,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.343246",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.",
      "url": "https://www.businesswire.com/news/home/20251110141838/en/SBC-Medical-Group-Announces-Commencement-of-Tender-Offer-for-Shares-of-Waqoo-Inc.",
      "time_published": "20251113T180932",
      "authors": [
        "NULL"
      ],
      "summary": "SBC Medical Group Holdings Incorporated announced a tender offer to acquire shares of Waqoo, Inc., a company listed on the Tokyo Stock Exchange Growth Market. This strategic move aims to integrate Waqoo's research and development capabilities to enhance SBC Group's offerings in clinical areas, skincare products, and regenerative medicine. The tender offer is for JPY 1,900 per share and will run from November 14 to December 12, 2025.",
      "banner_image": "https://mms.businesswire.com/media/20251110141838/en/2639695/4/SBC_logo_H_Gray_%286%29.jpg",
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.824934"
        },
        {
          "topic": "finance",
          "relevance_score": "0.718078"
        }
      ],
      "overall_sentiment_score": 0.436395,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.437892",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Inc Commences Tender Offer for Waqoo, Inc",
      "url": "https://www.tradingview.com/news/tradingview:c0146344cf0de:0-sbc-medical-group-holdings-inc-commences-tender-offer-for-waqoo-inc/",
      "time_published": "20251112T190907",
      "authors": [
        "NULL"
      ],
      "summary": "SBC Medical Group Holdings Inc (SBCMG) has announced a tender offer to acquire shares of Waqoo, Inc, aiming to make Waqoo a consolidated subsidiary. This move, which includes Dr. Aikawa transferring a significant number of shares to SBCMG, seeks to boost R&D and integrate Waqoo's technology into SBC's offerings. The tender offer is priced at JPY 1,900 per share, with settlement scheduled for December 19, 2025.",
      "banner_image": "NULL",
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.904873"
        },
        {
          "topic": "finance",
          "relevance_score": "0.720142"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.645005"
        }
      ],
      "overall_sentiment_score": 0.417961,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.419895",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical to Announce Q3 2025 Financial Results on November 14 and Hold Earnings Call on November 17",
      "url": "https://via.tt.se/pressmeddelande/4124162/sbc-medical-to-announce-q3-2025-financial-results-on-november-14-and-hold-earnings-call-on-november-17?publisherId=259167&lang=en",
      "time_published": "20251031T130000",
      "authors": [
        "Business Wire"
      ],
      "summary": "SBC Medical Group Holdings Incorporated will release its Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. The company will also host an Earnings Call on Monday, November 17, 2025, at 5:00 p.m. Eastern Time to discuss these financial results and answer questions. Registration for the call is required and will provide access to the viewing site, speaker information, and past investor relations materials.",
      "banner_image": "https://via.tt.se/data/images/public/259167/4124162/a382b9f9-624f-4f12-a440-90adb5f10706-w_300_h_100.jpg",
      "source": "Via TT",
      "category_within_source": "General",
      "source_domain": "Via TT",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940194"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.735235"
        }
      ],
      "overall_sentiment_score": 0.041518,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.315866",
          "ticker_sentiment_score": "0.046684",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Announces First Quarter 2025 Financial Results",
      "url": "https://www.businesswire.com/news/home/20250515682953/en/SBC-Medical-Group-Holdings-Announces-First-Quarter-2025-Financial-Results",
      "time_published": "20251021T060254",
      "authors": [],
      "summary": "SBC Medical Group Holdings announced its financial results for the first quarter ended March 31, 2025, reporting total revenues of $47 million, a 14% year-over-year decrease, and a net income attributable to SBC Medical Group of $22 million, a 15% year-over-year increase. The company's CEO highlighted strategic expansion efforts through enhanced platforms, optimized profitability, and revised pricing strategies, resulting in an improved operating margin. Despite the revenue decrease due to business discontinuation and divestitures, the company saw growth in partner clinics and an increase in net income, demonstrating resilience in its business model transition.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.927268"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.645589"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.527649"
        }
      ],
      "overall_sentiment_score": 0.03928,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.335711",
          "ticker_sentiment_score": "0.036263",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Will SBC Medical Group Holdings Incorporated Equity Warrant stock beat EPS estimates - Market Trend Review & Technical Pattern Recognition Alerts",
      "url": "https://nchmf.gov.vn/blank/Will-SBC-Medical-Group-Holdings-Incorporated-Equity-Warrant-stock-beat-EPS-estimates",
      "time_published": "20251021T060254",
      "authors": [],
      "summary": "This article is a server error page, indicating that the requested content is not available. The resource regarding SBC Medical Group Holdings Incorporated Equity Warrant stock and EPS estimates might have been removed, renamed, or is temporarily inaccessible.",
      "banner_image": null,
      "source": "Trung t\u00e2m D\u1ef1 b\u00e1o KTTV qu\u1ed1c gia",
      "category_within_source": "General",
      "source_domain": "Trung t\u00e2m D\u1ef1 b\u00e1o KTTV qu\u1ed1c gia",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.902444"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.516809"
        }
      ],
      "overall_sentiment_score": 0.009109,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.340091",
          "ticker_sentiment_score": "0.005780",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings Inc. Announces Fourth Quarter and Full Year 2024 Financial Results",
      "url": "https://www.businesswire.com/news/home/20250328660955/en/SBC-Medical-Group-Holdings-Inc.-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results",
      "time_published": "20251021T060254",
      "authors": [],
      "summary": "SBC Medical Group Holdings Inc. announced its financial results for the fourth quarter and full year 2024, highlighting a 6% year-over-year increase in total revenues to $205 million and an 18% increase in net income attributable to SBC Medical Group for the full year. The company also reported strong customer growth with 6.03 million customers and 251 partner clinics, and outlined strategic plans for 2025 including price revisions and franchise fee structure changes. The report also includes detailed financial statements and a reconciliation of GAAP to non-GAAP financial measures.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.927420"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.634439"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.521278"
        }
      ],
      "overall_sentiment_score": 0.030982,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.338836",
          "ticker_sentiment_score": "0.044764",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group (NASDAQ:SBC) Receives \u201cSell (D+)\u201d Rating from Weiss Ratings",
      "url": "https://www.defenseworld.net/2025/10/15/sbc-medical-group-nasdaqsbc-receives-sell-d-rating-from-weiss-ratings.html",
      "time_published": "20251016T074124",
      "authors": [
        "Defense World Staff"
      ],
      "summary": "SBC Medical Group (NASDAQ:SBC) recently received a \"Sell (D+)\" rating from Weiss Ratings. The article details recent changes in institutional investor positions, with several hedge funds acquiring new stakes in the company. SBC Medical Group operates clinics primarily in Japan, offering specialized medical services in cosmetic medicine, esthetic dentistry, and Androgenetic Alopecia.",
      "banner_image": null,
      "source": "Defense World",
      "category_within_source": "General",
      "source_domain": "Defense World",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.947554"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.704462"
        }
      ],
      "overall_sentiment_score": 0.049878,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.300327",
          "ticker_sentiment_score": "0.008709",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Emerging Growth Research Initiates Coverage on SBC Medical Group Holdings, Inc. with Buy-Extended Rating and $9.00 Price Target",
      "url": "https://www.newsfilecorp.com/release/265106/Emerging-Growth-Research-Initiates-Coverage-on-SBC-Medical-Group-Holdings-Inc.-with-BuyExtended-Rating-and-9.00-Price-Target?lang=fr",
      "time_published": "20250904T090000",
      "authors": [
        "NULL"
      ],
      "summary": "Emerging Growth Research has initiated coverage on SBC Medical Group Holdings, Inc. (NASDAQ: SBC) with a Buy-Extended rating and a $9.00 price target, significantly higher than its recent closing price. The report highlights SBC's market leadership in Japan's cosmetic treatment industry, strong balance sheet, and global expansion strategy, despite near-term revenue pressures. The analysis suggests SBC is undervalued and poised for long-term growth as a consolidator in the global cosmetic treatment industry.",
      "banner_image": "https://images.newsfilecorp.com/files/11409/265106_c734c4dc34684a8d_logo.jpg",
      "source": "TMX Newsfile",
      "category_within_source": "General",
      "source_domain": "TMX Newsfile",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.942175"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.835594"
        },
        {
          "topic": "finance",
          "relevance_score": "0.709245"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.932733"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.640630"
        }
      ],
      "overall_sentiment_score": 0.436427,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.411344",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Grows Franchises, Repeat Visits During First Half Of 2025 - Company Completes Share Buyback Program",
      "url": "https://www.newmediawire.com/news/sbc-medical-grows-franchises-repeat-visits-during-first-half-of-2025-company-completes-share-buyback-program-7082178",
      "time_published": "20250826T104400",
      "authors": [
        "Meg Flippin"
      ],
      "summary": "SBC Medical Group Holdings Inc. is undergoing a strategic transformation, expanding its cosmetic surgery franchises and increasing repeat customer visits despite a decline in overall revenue due to restructuring efforts. The company completed a share buyback program, reflecting management's confidence, and was added to the Russell 3000\u00ae Index, enhancing its market visibility. These strategic shifts are aimed at positioning SBC Medical as a leader in the cosmetic surgery market.",
      "banner_image": "https://www.newmediawire.com/_gallery/get_file/?file_id=68adc8efed6ae5340d5e56ed&file_ext=.161552cc0ede395b_68ada950da846f1ee1626d95_1&page_id=68adc8e5ed6ae5340d5e56e5",
      "source": "NewMediaWire",
      "category_within_source": "General",
      "source_domain": "NewMediaWire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.945620"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.718297"
        },
        {
          "topic": "finance",
          "relevance_score": "0.619182"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.542328"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.428530"
        }
      ],
      "overall_sentiment_score": 0.034645,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.344000",
          "ticker_sentiment_score": "0.048675",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Earnings call transcript: SBC Medical Group Q2 2025 results disappoint investors By Investing.com",
      "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-sbc-medical-group-q2-2025-results-disappoint-investors-93CH-4188592",
      "time_published": "20250813T092000",
      "authors": [
        "Investing.com"
      ],
      "summary": "SBC Medical Group reported disappointing Q2 2025 earnings, missing EPS estimates by 85.71% ($0.02 vs. $0.14 expected) and revenue by 11.69% ($43 million vs. $48.69 million forecasted). The company's stock dropped 9.03% in pre-market trading, reflecting investor concerns despite a strong financial health score and expansion plans. SBC Medical plans to open 1,000 clinics within the next decade and is actively pursuing growth opportunities through acquisitions and new clinic formats in orthopedics, fertility, and hair loss treatments.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.902814"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.706008"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.633626"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.503293"
        },
        {
          "topic": "finance",
          "relevance_score": "0.425611"
        }
      ],
      "overall_sentiment_score": 0.045205,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "0.347390",
          "ticker_sentiment_score": "0.026350",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq",
      "url": "https://www.businesswire.com/news/home/20240904728401/en/SBC-Medical-Group-Holdings-and-Pono-Capital-Two-Announce-Completion-of-Business-Combination-and-Schedule-to-Begin-Trading-on-the-Nasdaq",
      "time_published": "20241231T235959",
      "authors": [],
      "summary": "SBC Medical Group Holdings and Pono Capital Two have announced the completion of their business combination, with SBC Medical scheduled to begin trading on Nasdaq under the ticker symbol \"SBC\" on September 18, 2024. This transaction aims to provide SBC Medical with enhanced access to capital, accelerate expansion in the US and Southeast Asia, and grow its franchise clinic network. The company will continue to be led by CEO Yoshiyuki Aikawa and the current management team, focusing on medical innovation and delivering \"Japan Quality\" services globally.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "ipo",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.806255"
        },
        {
          "topic": "finance",
          "relevance_score": "0.618073"
        }
      ],
      "overall_sentiment_score": 0.477315,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.480850",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing",
      "url": "https://www.businesswire.com/news/home/20241115823816/en/SBC-Medical-Launches-SBC-Wellness-a-New-Solution-to-Help-Companies-Deliver-Additional-Health-Benefits-and-Enhance-Employee-Wellbeing",
      "time_published": "20241231T235959",
      "authors": [],
      "summary": "SBC Medical Group Holdings Incorporated launched SBC Wellness, a new solution for corporate clients to enhance employee benefits programs and well-being. This B2B initiative aims to improve employee satisfaction, recruitment, and retention, tapping into the growing corporate wellness market in Japan, projected to reach US$7.423 billion by 2028. SBC Wellness offers concierge services for cosmetic treatments, including fertility options, and is a major growth pillar for SBC Medical, with a five-year goal of partnering with 10% of Japan's largest companies.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.931537"
        },
        {
          "topic": "finance",
          "relevance_score": "0.728221"
        }
      ],
      "overall_sentiment_score": 0.439802,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.413982",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical To Acquire Singapore\u2019s AHH, Expanding Into Asia",
      "url": "https://www.bernama.com/en/news.php?id=2365079",
      "time_published": "20241119T154900",
      "authors": [],
      "summary": "SBC Medical Group Holdings Incorporated (SBC) announced its acquisition of Aesthetic Healthcare Holdings Pte Ltd (AHH), a Singapore-based aesthetic medical treatment provider, in an all-cash transaction. This acquisition is SBC's first step in its strategy to expand globally, focusing on the United States and Asia markets, and is expected to accelerate its entry into the Asian market. AHH's portfolio of four brands and 21 outlets will be added to SBC's network, strengthening its customer base in the region.",
      "banner_image": null,
      "source": "Bernama",
      "category_within_source": "General",
      "source_domain": "Bernama",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.949520"
        },
        {
          "topic": "finance",
          "relevance_score": "0.742240"
        }
      ],
      "overall_sentiment_score": 0.414672,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.426521",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "SBC Medical Group Lands US$700 Million Fortune for Founder After US SPAC Debut",
      "url": "https://www.globalcosmeticsnews.com/sbc-medical-group-lands-us700-million-fortune-for-founder-after-us-spac-debut/",
      "time_published": "20241022T000000",
      "authors": [
        "Global Cosmetics News"
      ],
      "summary": "SBC Medical Group Holdings Inc., Japan\u2019s largest operator of beauty clinics, recently went public in a US SPAC deal valued at over US$800 million. This move has landed a US$700 million fortune for its founder, capitalizing on the increasing global demand for cosmetic procedures fueled by social media and the normalization of beauty enhancements. The company operates more than 200 beauty clinics across Japan, offering a variety of cosmetic services.",
      "banner_image": null,
      "source": "Global Cosmetics News",
      "category_within_source": "General",
      "source_domain": "Global Cosmetics News",
      "topics": [
        {
          "topic": "ipo",
          "relevance_score": "0.940618"
        },
        {
          "topic": "finance",
          "relevance_score": "0.881413"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.716612"
        }
      ],
      "overall_sentiment_score": 0.525092,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SBC",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.542763",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    }
  ]
}